These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8612201)

  • 1. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease.
    Hardingham JE; Kotasek D; Sage RE; Eaton MC; Pascoe VH; Dobrovic A
    Mol Med; 1995 Nov; 1(7):789-94. PubMed ID: 8612201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction.
    Hardingham JE; Kotasek D; Farmer B; Butler RN; Mi JX; Sage RE; Dobrovic A
    Cancer Res; 1993 Aug; 53(15):3455-8. PubMed ID: 8101760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of K-Ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma.
    Etoh T; Ueo H; Inoue H; Sato K; Utsunomiya T; Barnard GF; Kitano S; Mori M
    Ann Surg Oncol; 2001 Jun; 8(5):407-12. PubMed ID: 11407514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.
    Thebo JS; Senagore AJ; Krygier S; Luchtefeld MA
    Am Surg; 2001 Aug; 67(8):802-5. PubMed ID: 11510588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.
    Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A
    Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of K-ras mutations in plasma after colorectal tumor resection.
    Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
    Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays.
    Kraus MC; Linnemann U; Berger MR
    Oncol Rep; 2011 May; 25(5):1421-9. PubMed ID: 21369707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
    Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer.
    Sefrioui D; Sarafan-Vasseur N; Beaussire L; Baretti M; Gangloff A; Blanchard F; Clatot F; Sabourin JC; Sesboüé R; Frebourg T; Michel P; Di Fiore F
    Dig Liver Dis; 2015 Oct; 47(10):884-90. PubMed ID: 26160500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
    Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
    World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer.
    Belly RT; Rosenblatt JD; Steinmann M; Toner J; Sun J; Shehadi J; Peacock JL; Raubertas RF; Jani N; Ryan CK
    Clin Colorectal Cancer; 2001 Aug; 1(2):110-6. PubMed ID: 12445369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations.
    Linnemann U; Schimanski CC; Gebhardt C; Berger MR
    Int J Colorectal Dis; 2004 Jul; 19(4):380-6. PubMed ID: 14634776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers.
    Guo J; Xiao B; Zhang X; Jin Z; Chen J; Qin L; Mao X; Shen G; Chen H; Liu Z
    J Mol Med (Berl); 2004 Nov; 82(11):768-74. PubMed ID: 15490093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
    Schimanski CC; Linnemann U; Berger MR
    Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease.
    Hardingham JE; Hewett PJ; Sage RE; Finch JL; Nuttall JD; Kotasek D; Dobrovic A
    Int J Cancer; 2000 Jan; 89(1):8-13. PubMed ID: 10719724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of postoperative detection of blood circulating tumor cells in patients with colorectal cancer operated on for cure.
    Bessa X; Piñol V; Castellví-Bel S; Piazuelo E; Lacy AM; Elizalde JI; Piqué JM; Castells A
    Ann Surg; 2003 Mar; 237(3):368-75. PubMed ID: 12616121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.